Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 22.62
+0.44 (1.98%)
At close: Sep 25, 2026
Cian Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 282.99 | 307.98 | 616.96 | 685.9 | 778.7 |
Other Revenue | - | 0.55 | 1.96 | 0.86 | 1.95 |
| 282.99 | 308.54 | 618.92 | 686.76 | 780.66 | |
Revenue Growth | -8.28% | -50.15% | -9.88% | -12.03% | 5.58% |
Cost of Revenue | 229.32 | 230.18 | 313.51 | 340.88 | 486.5 |
Gross Profit | 53.67 | 78.36 | 305.4 | 345.88 | 294.16 |
Selling, General & Admin | 61.97 | 74.77 | 97.76 | 101.31 | 104.48 |
Other Operating Expenses | 57.97 | 68.85 | 94.99 | 113.81 | 144.06 |
Operating Expenses | 159.09 | 187.54 | 247.41 | 269.43 | 291.29 |
Operating Income | -105.42 | -109.18 | 57.99 | 76.45 | 2.86 |
Interest Expense | -4.91 | -26.27 | -55.86 | -57.83 | -61.64 |
Interest & Investment Income | 3.93 | 1.51 | 1.04 | 1.41 | 1.61 |
Currency Exchange Gain (Loss) | 6.34 | 0.57 | 1.4 | 3.75 | 1.68 |
Other Non Operating Income (Expenses) | 1.23 | -4.05 | -4.09 | -5.02 | -3.8 |
EBT Excluding Unusual Items | -98.83 | -137.42 | 0.48 | 18.77 | -59.3 |
Other Unusual Items | -132.98 | -122.54 | 0.04 | 1.14 | -0.73 |
Pretax Income | -231.81 | -259.95 | 0.52 | 19.91 | -60.03 |
Income Tax Expense | 1.12 | -0.18 | -7.97 | -0.39 | -4.7 |
Net Income | -232.93 | -259.78 | 8.49 | 20.3 | -55.34 |
Net Income to Common | -232.93 | -259.78 | 8.49 | 20.3 | -55.34 |
Net Income Growth | - | - | -58.19% | - | - |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 |
Shares Change | 0.01% | -0.00% | 0.00% | - | -5.85% |
EPS (Basic) | -9.32 | -10.39 | 0.34 | 0.81 | -2.21 |
EPS (Diluted) | -9.32 | -10.39 | 0.34 | 0.81 | -2.21 |
EPS Growth | - | - | -58.09% | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -22.92 | 203.46 | 107.85 | 35.16 | -87.4 |
Free Cash Flow Per Share | -0.92 | 8.14 | 4.32 | 1.41 | -3.50 |
Gross Margin | 18.96% | 25.40% | 49.34% | 50.36% | 37.68% |
Operating Margin | -37.25% | -35.39% | 9.37% | 11.13% | 0.37% |
Profit Margin | -82.31% | -84.20% | 1.37% | 2.96% | -7.09% |
Free Cash Flow Margin | -8.10% | 65.94% | 17.43% | 5.12% | -11.20% |
EBITDA | -66.27 | -65.27 | 112.66 | 130.76 | 45.61 |
EBITDA Margin | -23.42% | -21.15% | 18.20% | 19.04% | 5.84% |
D&A For EBITDA | 39.15 | 43.91 | 54.67 | 54.31 | 42.75 |
EBIT | -105.42 | -109.18 | 57.99 | 76.45 | 2.86 |
EBIT Margin | -37.25% | -35.39% | 9.37% | 11.13% | 0.37% |
Revenue as Reported | 294.69 | 310.67 | 621.36 | 692.08 | 784.07 |
Advertising Expenses | 0.16 | 0.48 | 8.53 | 2.26 | 1.78 |